6 source-based articles maintained by the HealthRX.com Editorial Team.
Showing 6 of 6 clinical reviews.
What GlycoMark (1,5-AG) measures, its reference range and a proposed optimal target, whether an at-home or finger-prick version exists, and how to interpret a result alongside HbA1c and CGM data. Pending qualified medical review.
A decade-by-decade guide to GlycoMark (1,5-anhydroglucitol) reference ranges, the tradeoffs in interpreting them, and the confounders that can make a result misleading, with an evidence-boundary framework for reading your own report.
A guide to GlycoMark (1,5-anhydroglucitol) reference ranges, longevity-medicine target ranges, and what the evidence does and does not establish about postprandial glucose excursions and long-term metabolic health.
GlycoMark (1,5-AG) drops sharply with SGLT-2 inhibitors and can fall after GLP-1 agonists. Learn which drugs alter 1,5-anhydroglucitol, how to interpret results during treatment, and what the optimal range looks like for metabolic health.
Learn how diet, fasting, carbohydrate intake, and postprandial glucose spikes alter GlycoMark (1,5-AG) levels, what the optimal range is, and how to interpret your result in clinical context.
How biological sex, menstrual cycle phase, pregnancy, menopause, and sex-hormone therapy each shift GlycoMark (1,5-AG) values, what the normal and optimal ranges are, and how to interpret results correctly in male and female patients.